Certara
在场
高管
查看带有其 24 名主要高管的组织结构图
Certara 搜索最多的简介
- William Feehery, Chief Executive Officer and Director
- Stephen McLean, Director
- Matthew Walsh, Director
高管在Certara变化
- John Reynders已作为Independent Board Member加入公司 (新闻发布的2024十月18号).
- Daniel Corcoran已作为General Counsel加入公司 (新闻发布的2024五月22号).
- Rona Anhalt已作为Chief Human Resources Officer加入公司 (新闻发布的2024五月22号).
创建提醒
跟踪 Certara 的高管变动
药店
Certara 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- Bain Capital 已收购 Mitsubishi Tanabe Pharma (公布2025二月12号).
- Crown Laboratories 已收购 Revance Therapeutics (公布2025二月9号).
- Revance Therapeutics has announced the acquisition of Revance Therapeutics (公布2025一月14号).
药店 行业的其他推荐联系人
消息
Certara 的最新新闻稿
- Certara Showcases 2024 Research Wins with Over 100 Papers Published
- Certara Reports Third Quarter 2024 Financial Results
- Certara Appoints John Reynders as New Independent Board Member
- Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
- Certara Completes Acquisition of Chemaxon
- Certara’s Simcyp Consortium Celebrates 25th Anniversary
- Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
- Certara to Participate in Upcoming Investor Conferences
- Certara Reports Second Quarter 2024 Financial Results
- Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
- View more press releases Close
